| Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma (NCT05108428) | H. Lee Moffitt Cancer Center and Research Institute | 2021-12-23 |
| ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation (NCT05059444) | Guardant Health, Inc. | 2021-09-07 |
| Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer (NCT05081024) | OHSU Knight Cancer Institute | 2021-09-03 |
| Neoadjuvant Therapy for Localized Rectal Adenocarcinoma (NCT04418895) | UNC Lineberger Comprehensive Cancer Center | 2021-08-13 |
| Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer (NCT04963283) | University of Colorado, Denver | 2021-06-23 |
| MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer (NCT04808323) | Medical College of Wisconsin | 2021-06-17 |
| The Safety and Feasibility of MONOFIX on Fascial Closure of Mid-line Wound After Minimally Invasive Colorectal Cancer Surgery (NCT05872334) | Samsung Medical Center | 2021-06-01 |
| Role of Neoadjuvent Radiotherapy in Locally Advanced Cancer Rectum (NCT04814784) | Amany sayed Abass | 2021-03-31 |
| Testing the Addition of a Radiation Sensitizing Drug, IPdR, to the Usual Chemotherapy Treatment (Capecitabine) During Radiation Therapy for Rectal Cancer (NCT04406857) | National Cancer Institute (NCI) | 2021-03-17 |
| Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer (NCT04703101) | Jonsson Comprehensive Cancer Center | 2021-02-11 |
| A Trial of Durvalumab (MEDI 4736) in Combination With Extended Neoadjuvant Regimens in Rectal Cancer (NCT04621370) | Liz-Anne Lewsley | 2020-12-07 |
| Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems (NCT03961776) | Institut Paoli-Calmettes | 2020-06-08 |
| Assessing the Additional Neoplasia Yield of Computer-aided Colonoscopy in a Screening Setting (NCT04441580) | Fondazione Poliambulanza Istituto Ospedaliero | 2020-05-04 |
| Mechanical Bowel Preparation and Oral Antibiotics Versus Mechanical Bowel Preparation Only Prior Rectal Surgery (NCT04281667) | Helsinki University Central Hospital | 2020-03-18 |
| Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors (NCT04165772) | Memorial Sloan Kettering Cancer Center | 2019-12-11 |
| TAS-102 With Concurrent Radiation for the Treatment of Untreated Resectable Stage II-III Rectal Cancer (NCT04104139) | OHSU Knight Cancer Institute | 2019-12-11 |
| Optimisation of Radiotherapy in Rectal Cancer (ORREC) (NCT04090450) | University of Manchester | 2019-09-23 |
| Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer (NCT03300544) | National Cancer Institute (NCI) | 2019-05-14 |
| Peptide-based Immunization for Colon- and and Pancreas-carcinoma (NCT03871790) | CENTOGENE GmbH Rostock | 2019-04-01 |
| Chimney Trial of Parastomal Hernia Prevention (NCT03799939) | University of Oulu | 2019-02-05 |
| Chemo-radiotherapy as Main Treatment Strategy for Rectal Cancer. Can we Provide a More Precise and Effective Treatment (NCT03619668) | Aalborg University Hospital | 2018-06-29 |
| Prestoma-Trial for Parastomal Hernia Prevention (NCT03527784) | University of Oulu | 2018-05-03 |
| Audit of Surgery for Colorectal Cancer (NCT04349384) | Institut National d'Oncologie, Morocco | 2018-01-01 |
| TAS-102 and Radiation Therapy in Treating Patients With Rectal Cancer That Is Locally Recurrent, Metastatic, or Cannot Be Removed by Surgery (NCT03297710) | Mayo Clinic | 2017-12-11 |
| S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery (NCT03365882) | SWOG Cancer Research Network | 2017-11-27 |
| Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer (NCT02921256) | National Cancer Institute (NCI) | 2017-01-11 |
| Capecitabine and Lenvatinib With External Radiation in Rectal Adenocarcinoma (NCT02935309) | H. Lee Moffitt Cancer Center and Research Institute | 2016-10-14 |
| ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer (NCT02688712) | Providence Health & Services | 2016-03-24 |
| Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer (NCT02393755) | Roswell Park Cancer Institute | 2015-05-08 |
| Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer (NCT02368886) | Academic and Community Cancer Research United | 2015-03-27 |
| Regorafenib in Reducing Recurrence in Patients With Non-metastatic Rectal Cancer Who Have Completed Curative-Intent Treatment (NCT02287727) | Roswell Park Cancer Institute | 2015-03-01 |
| Pelvic Radiotherapy With Concurrent Neoadjuvant FOLFOX for Patients With Newly Diagnosed Rectal Adenocarcinoma (NCT02319304) | University of Maryland, Baltimore | 2015-03-01 |
| Prospective Validation Study for the Proprietary Rectal and Anal Cancer Protein Expression Assays (NCT02407561) | Castle Biosciences Incorporated | 2015-02-01 |
| Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal Cancer (NCT02270606) | Virginia Commonwealth University | 2014-12-04 |
| Neo-adjuvant Chemoradiotherapy Using Infusional Gemcitabine Followed by Surgery for Locally Advanced Rectal Cancer (NCT02919878) | King Faisal Specialist Hospital & Research Center | 2014-12-01 |
| GRECCAR 8: Primary Tumor Resection in Rectal Cancer With Unresectable Metastasis (NCT02314182) | Hospices Civils de Lyon | 2014-11-20 |
| Evaluation of Rectal Cancer Treatment Response Using PET/MRI (NCT02233595) | University of California, San Francisco | 2014-10-15 |
| Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer (NCT02107105) | M.D. Anderson Cancer Center | 2014-05-16 |
| Immunoscore in Rectal Cancer (NCT02017509) | Providence Health & Services | 2014-01-24 |
| Evaluation of Rectal Tumor Margin Using Confocal Endomicroscopy and Comparison to Histopathology (NCT01887509) | IHU Strasbourg | 2013-11-07 |
| Neoadjuvant Chemoradiation With Bevacizumab for Chinese Rectal Cancer Patients (NCT01554059) | Sixth Affiliated Hospital, Sun Yat-sen University | 2012-03-01 |
| Interest of Saline MR Peritoneography for Pre-operative Assessment of Rectal Cancer (NCT01497457) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2011-12-01 |
| Extralevator Versus Standard Abdominoperineal Resection For Rectal Adenocarcinoma (NCT01702116) | Stony Brook University | 2011-07-01 |
| Prospective Pilot Study of Multimodal Radiological Evaluation Feasibility During Chemoradiotherapy of Rectal Adenocarcinomas (NCT01619696) | University Hospital, Toulouse | 2011-03-01 |
| Proteomic Approach Using Matrix-assisted Laser Desorption/Ionization Tandem Time-of-flight (MALDI-TOF/TOF) of Tumor Response in Rectal Carcinoma After Radiochemotherapy (NCT00855946) | University Hospital, Bordeaux | 2009-05-01 |
| Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer (NCT00321685) | National Cancer Institute (NCI) | 2006-07-25 |
| Avoiding Surgery in Rectal Cancer After Pre-Operative Therapy (NCT01047969) | Royal Marsden NHS Foundation Trust | 2006-06-06 |
| Factors Predicting Recurrence in Rectal Cancer After Surgery (NCT03899870) | ammar houssem | 2000-01-01 |
| Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer (NCT02575508) | Roswell Park Cancer Institute | |